Category: Diseases & Conditions
Diseases & Conditions market research reports by GlobalData
-
China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More
-
Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Sum ... Read More
-
Italy General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Italy General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030 Summary GlobalData’s “Italy General Surgery Device Procedures Outlook to 2030” is a c ... Read More
-
South Korea General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
South Korea General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030 Summary GlobalData’s “South Korea General Surgery Device Procedures Outlook to ... Read More
-
Brazil General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Brazil General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030 Summary GlobalData’s “Brazil General Surgery Device Procedures Outlook to 2030” is a ... Read More
-
Canada General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Canada General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030 Summary GlobalData’s “Canada General Surgery Device Procedures Outlook to 2030” is a ... Read More
-
Russia General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Russia General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030 Summary GlobalData’s “Russia General Surgery Device Procedures Outlook to 2030” is a ... Read More
-
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More
-
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More
-
Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More
-
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast t ... Read More
-
North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uter
North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 ... Read More
-
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for markete ... Read More
-
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for m ... Read More
-
Spondyloarthritis (Spondyloarthropathy) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Spondyloarthritis (Spondyloarthropathy) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Spondyloarthritis (Spondyloarthropathy) - Global Clinical Trials Review, 2023 provi ... Read More
-
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2023 provides an overview of O ... Read More
-
Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2023 provides an overview of D ... Read More
-
Brexit and the Healthcare Industry - Thematic Intelligence
Brexit and the Healthcare industry - Thematic Intelligence Summary In this report, GlobalData examines the business environment, weighs the challenges and opportunities, and assesses the risks that the UK’s healthcare sector is continuing to face post-Brexit. The report also highlights the impact fr ... Read More
-
Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. There will be more than 1 billion prevalent cases of AC in 2023 in t ... Read More
-
Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 Summary The report provides an in-depth assessment of the MS market including disease overview, epide ... Read More
-
Obesity Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
Obesity Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 Summary Obesity is a complex multifactorial disease characterized by an excess of adipose tissue. It results from an ... Read More
-
Alzheimer's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Alzheimer's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Alzheimer's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Sta ... Read More
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) C ... Read More
-
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033 Summary Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape ... Read More
Research Assistance
